V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220005579 | 220002182 | null | null | Palliative (P) | 2014-01-25 | 2014-01-27 | Cytarabine Low Dose | N | N | 220028504 | CYTARABINE |
| 220005580 | 220002182 | 0 | 58 | Palliative (P) | 2017-10-16 | 2017-10-16 | Cytarabine low (10to20mg/m2) IV/SC | 02 | N | 220028504 | CYTARABINE |
| 220005583 | 220002184 | 1.63 | 80.8 | Curative (C) | 2015-09-12 | 2015-09-19 | AML17 TRIAL | N | N | 220028513 | AML17 TRIAL |
| 220005584 | 220002184 | 1.63 | 54.8 | Curative (C) | null | 2017-05-18 | AML17 TRIAL | N | N | 220028513 | AML17 TRIAL |
| 220005585 | 220002185 | 0 | null | Curative (C) | 2015-12-11 | 2015-12-11 | AML17 TRIAL | N | N | 220028517 | AML17 TRIAL |
| 220005586 | 220002185 | 1.68 | 95.4 | Curative (C) | 2015-03-13 | 2015-03-13 | Trial Unspecified | 1 | N | 220028517 | TRIAL |
| 220005587 | 220002185 | null | 72.7 | Palliative (P) | 2013-05-30 | 2013-06-05 | Cytarabine low (10to20mg/m2) IV/SC | 02 | N | 220028517 | CYTARABINE |
| 220005588 | 220002185 | null | 69 | Curative (C) | null | 2016-03-03 | Trial Unspecified | Y | N | 220028517 | TRIAL |
| 220005589 | 220002186 | 1.67 | 88.6 | Curative (C) | null | 2013-04-18 | AML17 TRIAL | N | N | 220028526 | AML17 TRIAL |
| 220005590 | 220002186 | 1.57 | 74 | null | null | 2013-11-13 | Cytarabine Low Dose | 2 | N | 220028526 | CYTARABINE |
| 220005591 | 220002187 | 1.77 | 111 | Curative (C) | 2017-01-24 | 2017-01-24 | AML17 TRIAL | N | N | 220028529 | AML17 TRIAL |
| 220005592 | 220002188 | null | 69.4 | Disease modification (D) | 2017-12-30 | 2017-12-30 | Trial Unspecified | 01 | N | 220028533 | TRIAL |
| 220005593 | 220002188 | 1.7 | 82.1 | Curative (C) | 2017-01-15 | 2017-01-15 | Trial Unspecified | Y | N | 220028533 | TRIAL |
| 220005594 | 220002188 | 1.83 | 97.8 | Curative (C) | 2016-11-14 | 2016-11-15 | Trial Unspecified | Y | N | 220028533 | TRIAL |
| 220005595 | 220002188 | null | null | Palliative (P) | 2015-04-01 | 2015-04-01 | Cytarabine low (10to20mg/m2) IV/SC | Y | N | 220028533 | CYTARABINE |
| 220005598 | 220002190 | 1.77 | 104 | Palliative (P) | 2015-04-01 | 2015-04-01 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220028547 | CYTARABINE |
| 220005599 | 220002190 | 1.65 | 45 | Palliative (P) | 2017-06-14 | 2017-06-14 | Cytarabine Low Dose | 02 | N | 220028547 | CYTARABINE |
| 220005600 | 220002191 | 1.74 | 77.5 | Curative (C) | 2016-02-17 | 2016-02-22 | AML17 TRIAL | N | N | 220028552 | AML17 TRIAL |
| 220005601 | 220002192 | 1.73 | 64.4 | Curative (C) | 2016-03-10 | 2016-03-10 | AML17 TRIAL | Y | N | 220028553 | AML17 TRIAL |
| 220005602 | 220002193 | 1.68 | 62.4 | Curative (C) | 2013-12-03 | 2013-12-07 | AML17 TRIAL | 1 | null | 220028558 | AML17 TRIAL |
| 220005603 | 220002193 | 1.79 | 58.4 | Not known (9) | 2013-07-06 | 2013-07-07 | AML17 TRIAL | 02 | N | 220028558 | AML17 TRIAL |
| 220005604 | 220002193 | 1.71 | 69.6 | Curative (C) | 2017-06-17 | 2017-06-18 | AML17 TRIAL | N | N | 220028558 | AML17 TRIAL |
| 220005605 | 220002193 | null | 88.3 | Curative (C) | 2017-04-24 | 2017-04-24 | AML17 TRIAL | 01 | N | 220028558 | AML17 TRIAL |
| 220005606 | 220002193 | 1.65 | null | Curative (C) | 2012-12-25 | 2013-01-22 | Cytarabine Low Dose | 02 | null | 220028558 | CYTARABINE |
| 220005607 | 220002193 | 1.31 | 98 | Not known (9) | null | 2015-01-20 | AML17 TRIAL | N | N | 220028558 | AML17 TRIAL |
| 220005608 | 220002194 | null | null | Curative (C) | 2016-01-20 | 2016-01-20 | Trial Unspecified | N | N | 220028567 | TRIAL |
| 220005609 | 220011201 | null | null | Curative (C) | 2017-11-18 | 2017-11-21 | Trial Unspecified | 01 | null | 220028571 | TRIAL |
| 220005610 | 220002195 | null | 88 | Curative (C) | 2014-02-17 | 2014-02-19 | Trial Unspecified | Y | N | 220028572 | TRIAL |
| 220005611 | 220011202 | 1.73 | 86.8 | null | 2017-11-09 | 2017-11-09 | CYTARABINE | 99 | N | 220028574 | CYTARABINE |
| 220005612 | 220011202 | 1.82 | 60.3 | Curative (C) | 2014-02-25 | 2014-03-07 | Trial Unspecified | 1 | N | 220028574 | TRIAL |
| 220005613 | 220002196 | 1.56 | 91.5 | Curative (C) | 2014-06-10 | 2014-06-10 | AML17 TRIAL | Y | null | 220028579 | AML17 TRIAL |
| 220005614 | 220011203 | 1.66 | 51.5 | Palliative (P) | 2014-01-23 | 2014-01-23 | Cytarabine Low Dose | N | N | 220028580 | CYTARABINE |
| 220005615 | 220011203 | 0 | null | Disease modification (D) | 2016-02-16 | 2016-02-17 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220028580 | CYTARABINE |
| 220005616 | 220002197 | 1.77 | 55 | Curative (C) | 2015-03-26 | 2015-03-27 | Trial Unspecified | Y | N | 220028584 | TRIAL |
| 220005617 | 220011204 | 1.75 | null | Disease modification (D) | 2015-06-15 | 2015-06-23 | CYTARABINE | N | N | 220028585 | CYTARABINE |
| 220005618 | 220002198 | 1.52 | 79.4 | Disease modification (D) | null | 2013-06-14 | Trial Unspecified | Y | Y | 220028590 | TRIAL |
| 220005619 | 220002199 | null | 64.8 | Palliative (P) | 2014-01-25 | 2014-01-26 | Cytarabine Low Dose | N | null | 220028599 | CYTARABINE |
| 220005620 | 220002200 | null | 80.9 | Disease modification (D) | 2015-10-21 | 2015-10-21 | Trial Unspecified | 1 | N | 220028601 | TRIAL |
| 220005621 | 220002200 | 1.73 | 79.4 | Curative (C) | 2014-09-01 | 2014-09-01 | Trial Unspecified | Y | null | 220028601 | TRIAL |
| 220005622 | 220002200 | 0 | 62.5 | null | 2013-05-04 | 2013-05-04 | CYTARABINE | 1 | N | 220028601 | CYTARABINE |
| 220005623 | 220002201 | 1.69 | null | Curative (C) | 2014-07-18 | 2014-07-18 | Cytarabine Low Dose | N | N | 220028611 | CYTARABINE |
| 220005624 | 220002201 | 1.69 | 0 | Not known (9) | 2015-02-14 | 2015-02-14 | Cytarabine Low Dose | N | N | 220028611 | CYTARABINE |
| 220005625 | 220002202 | 1.59 | null | Palliative (P) | 2015-03-24 | 2015-03-26 | Cytarabine Low Dose | Y | null | 220028614 | CYTARABINE |
| 220005626 | 220002202 | 1.73 | 76.3 | Not known (9) | 2017-07-18 | 2017-07-20 | Cytarabine Low Dose | Y | N | 220028614 | CYTARABINE |
| 220005627 | 220002202 | 1.88 | null | Curative (C) | 2018-04-25 | 2018-04-25 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220028614 | CYTARABINE |
| 220005628 | 220002203 | 1.68 | 82.3 | Curative (C) | 2017-07-27 | 2017-08-01 | AML17 TRIAL | 1 | N | 220028627 | AML17 TRIAL |
| 220005629 | 220002203 | 0 | 92 | Disease modification (D) | 2013-09-03 | 2013-09-03 | Cytarabine Low Dose | 2 | N | 220028627 | CYTARABINE |
| 220005630 | 220002204 | null | 87 | Curative (C) | 2013-07-16 | 2013-07-16 | AML17 TRIAL | 02 | N | 220028630 | AML17 TRIAL |
| 220005631 | 220002204 | null | null | Curative (C) | 2015-08-28 | 2015-08-28 | AML17 TRIAL | 02 | N | 220028630 | AML17 TRIAL |
| 220005632 | 220002204 | 1.6 | 74.5 | Disease modification (D) | 2015-01-21 | 2015-01-23 | Trial Unspecified | 1 | N | 220028630 | TRIAL |